These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19671684)

  • 1. A novel function of CXCL13 to stimulate RANK ligand expression in oral squamous cell carcinoma cells.
    Yuvaraj S; Griffin AC; Sundaram K; Kirkwood KL; Norris JS; Reddy SV
    Mol Cancer Res; 2009 Aug; 7(8):1399-407. PubMed ID: 19671684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment.
    Sambandam Y; Sundaram K; Liu A; Kirkwood KL; Ries WL; Reddy SV
    Oncogene; 2013 Jan; 32(1):97-105. PubMed ID: 22330139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice.
    Pandruvada SN; Yuvaraj S; Liu X; Sundaram K; Shanmugarajan S; Ries WL; Norris JS; London SD; Reddy SV
    Int J Cancer; 2010 May; 126(10):2319-29. PubMed ID: 19816883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoregulation of RANK ligand in oral squamous cell carcinoma tumor cells.
    Sambandam Y; Ethiraj P; Hathaway-Schrader JD; Novince CM; Panneerselvam E; Sundaram K; Reddy SV
    J Cell Physiol; 2018 Aug; 233(8):6125-6134. PubMed ID: 29323724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RANKL triggers resistance to TRAIL-induced cell death in oral squamous cell carcinoma.
    Ethiraj P; Sambandam Y; Hathaway-Schrader JD; Haque A; Novince CM; Reddy SV
    J Cell Physiol; 2020 Feb; 235(2):1663-1673. PubMed ID: 31309556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1α,25-dihydroxyvitamin D3 modulates CYP2R1 gene expression in human oral squamous cell carcinoma tumor cells.
    Sundaram K; Sambandam Y; Tsuruga E; Wagner CL; Reddy SV
    Horm Cancer; 2014 Apr; 5(2):90-7. PubMed ID: 24497297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis.
    Biswas S; Sengupta S; Roy Chowdhury S; Jana S; Mandal G; Mandal PK; Saha N; Malhotra V; Gupta A; Kuprash DV; Bhattacharyya A
    Breast Cancer Res Treat; 2014 Jan; 143(2):265-76. PubMed ID: 24337540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts.
    Lee HL; Bae OY; Baek KH; Kwon A; Hwang HR; Qadir AS; Park HJ; Woo KM; Ryoo HM; Baek JH
    Bone; 2011 Aug; 49(2):242-9. PubMed ID: 21514407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum CXCL13 as a Novel Biomarker in Oral Squamous Cell Carcinoma.
    Tojo S; Nakashiro KI; Kuribayashi N; Uchida D
    Cancer Med; 2024 Sep; 13(18):e70263. PubMed ID: 39344390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RANK Ligand Modulation of Autophagy in Oral Squamous Cell Carcinoma Tumor Cells.
    Sambandam Y; Sakamuri S; Balasubramanian S; Haque A
    J Cell Biochem; 2016 Jan; 117(1):118-25. PubMed ID: 26095774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral squamous carcinoma cells secrete RANKL directly supporting osteolytic bone loss.
    Zhang X; Junior CR; Liu M; Li F; D'Silva NJ; Kirkwood KL
    Oral Oncol; 2013 Feb; 49(2):119-28. PubMed ID: 22989723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a xenograft model to explore the mechanism of bone destruction by human oral cancers and its application to analysis of role of RANKL.
    Tohyama R; Kayamori K; Sato K; Hamagaki M; Sakamoto K; Yasuda H; Yamaguchi A
    J Oral Pathol Med; 2016 May; 45(5):356-64. PubMed ID: 26859422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
    Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT-6 mediates TRAIL induced RANK ligand expression in stromal/preosteoblast cells.
    Sundaram K; Sambandam Y; Balasubramanian S; Pillai B; Voelkel-Johnson C; Ries WL; Reddy SV
    Bone; 2015 Feb; 71():137-44. PubMed ID: 25445452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DACH1 negatively regulates the human RANK ligand gene expression in stromal/preosteoblast cells.
    Sundaram K; Mani SK; Kitatani K; Wu K; Pestell RG; Reddy SV
    J Cell Biochem; 2008 Apr; 103(6):1747-59. PubMed ID: 17891780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation.
    Ikeda F; Nishimura R; Matsubara T; Tanaka S; Inoue J; Reddy SV; Hata K; Yamashita K; Hiraga T; Watanabe T; Kukita T; Yoshioka K; Rao A; Yoneda T
    J Clin Invest; 2004 Aug; 114(4):475-84. PubMed ID: 15314684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathways involved in crosstalk between cancer cells, osteoblasts and osteoclasts in the invasion of bone by oral squamous cell carcinoma.
    Quan J; Zhou C; Johnson NW; Francis G; Dahlstrom JE; Gao J
    Pathology; 2012 Apr; 44(3):221-7. PubMed ID: 22406484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RelA driven co-expression of CXCL13 and CXCR5 is governed by a multifaceted transcriptional program regulating breast cancer progression.
    Biswas S; Roy Chowdhury S; Mandal G; Purohit S; Gupta A; Bhattacharyya A
    Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):502-511. PubMed ID: 30553016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
    Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
    Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.